News ArticleMore News »
Novum's Keith Gallicano, Ph.D., was invited to Present at the 2014 GPhA Fall Technical Conference
Oct 14, 2014
Pittsburgh, PA: Keith Gallicano, Ph.D., Novum's Vice President, Scientific Affairs, was a Presenter on Day 2 of the GPhA Fall Technical Conference. He joined a panel of experts during the Bioequivalence – Clinical Safety Session on Wednesday, October 29th at 8:30 a.m.; Dr. Gallicano presented on the topic "Design and Data Analysis Challenges for Establishing Therapeutic Equivalence in Clinical Endpoint Studies."
As Vice President, Scientific Affairs, Keith leads the Novum team responsible for protocol development, medical writing and biostatistics. His presentation, as his work, draws on 26 years of experience in the pharmaceutical field where he has held a variety of positions in a diverse range of industries that include government, academia, the pharmaceutical manufacturing industry and the CRO service industry.